Medartis Holding AG (MDRSF)
115.00
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Medartis Research and Development Expense (TTM) : 43.03M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.03M |
| December 31, 2025 | 38.08M |
| June 30, 2025 | 39.79M |
| December 31, 2024 | 48.93M |
| June 30, 2024 | 39.00M |
| December 31, 2023 | 28.82M |
| June 30, 2023 | 28.38M |
| December 31, 2022 | 26.52M |
| June 30, 2022 | 23.21M |
| Date | Value |
|---|---|
| December 31, 2021 | 21.94M |
| June 30, 2021 | 20.76M |
| December 31, 2020 | 17.26M |
| June 30, 2020 | 15.18M |
| December 31, 2019 | 14.63M |
| June 30, 2019 | 13.95M |
| December 31, 2018 | 13.52M |
| June 30, 2018 | 13.14M |
| December 31, 2017 | 11.55M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Medacta Group SA | 25.92M |
| Straumann Holding AG | -- |
| Metall Zug AG | 29.03M |
| Alcon AG | 1.431B |
| Ypsomed Holding AG | 49.92M |